A 35-year-old woman undergoes mammography for routine screening and is found to have a 1.5 cm lesion with clustered microcalcifications in the left breast. Clinical examination is unremarkable. What is the most appropriate next investigation to establish a tissue diagnosis?

Explanation

## Tissue Diagnosis of Microcalcifications on Mammography ### Why Stereotactic Core Needle Biopsy is Indicated **Key Point:** Clustered microcalcifications on mammography are a BI-RADS 4–5 finding requiring tissue diagnosis. Stereotactic core needle biopsy is the gold standard for lesions visible on mammography but not on ultrasound. **High-Yield:** Stereotactic core needle biopsy offers: - High diagnostic accuracy (95–99%) - Ability to target lesions visible only on mammography (microcalcifications) - Lower cost and faster turnaround than excisional biopsy - Minimally invasive with low complication rates - Allows tissue diagnosis without surgical excision ### BI-RADS Classification and Management | BI-RADS | Description | Malignancy Risk | Management | |---|---|---|---| | **1–2** | Normal/benign | <2% | Routine screening | | **3** | Probably benign | 2–10% | Short-interval follow-up (6 months) | | **4** | Suspicious abnormality | 10–95% | **Tissue diagnosis required** | | **5** | Malignant | >95% | Tissue diagnosis + treatment | Clustered microcalcifications typically fall into **BI-RADS 4–5**, mandating tissue diagnosis. ### Comparison of Diagnostic Approaches for Microcalcifications | Investigation | Utility | Limitation | |---|---|---| | **Stereotactic CNB** | Gold standard; targets microcalcifications directly | Requires mammography suite | | Ultrasound | May visualize mass if present; cannot target microcalcifications alone | Microcalcifications not visible on ultrasound | | MRI | High sensitivity; useful for multifocal disease | Low specificity; not first-line for microcalcifications | | Repeat mammography | Appropriate only for BI-RADS 3 (benign) lesions | Delays diagnosis in suspicious lesions; not appropriate for BI-RADS 4–5 | ### Clinical Pearl **Microcalcifications are a hallmark of ductal carcinoma in situ (DCIS) and invasive carcinoma.** Any clustered or linear microcalcifications require tissue diagnosis to exclude malignancy. Stereotactic core needle biopsy is minimally invasive, highly accurate, and avoids unnecessary surgical excision if benign pathology is confirmed. ### Diagnostic Algorithm for Mammographic Abnormalities ```mermaid flowchart TD A["Mammographic abnormality detected"]:::outcome --> B{"BI-RADS classification?"}:::decision B -->|"BI-RADS 1–2: Benign"| C["Routine screening"]:::action B -->|"BI-RADS 3: Probably benign"| D["Short-interval follow-up 6 months"]:::action B -->|"BI-RADS 4–5: Suspicious/Malignant"| E{"Lesion type?"}:::decision E -->|"Microcalcifications only"| F["Stereotactic core needle biopsy"]:::action E -->|"Mass visible on ultrasound"| G["Ultrasound-guided core needle biopsy"]:::action E -->|"Architectural distortion"| H["Stereotactic or excisional biopsy"]:::action F --> I["Tissue diagnosis obtained"]:::outcome G --> I H --> I ``` [cite:Sabiston Textbook of Surgery Ch 36]